Medtronic, a healthcare technology company, and DaVita, a comprehensive kidney care provider, agreed to form a joint venture, enhance the patient treatment experience and improve overall outcomes. Financial terms were not disclosed. "This is an exciting moment that will shape the future of kidney care. Our singular focus on end-to-end kidney health solutions will position this new company to make a measurable difference in the lives of more than three million patients with kidney failure globally - a figure expected to double over the next decade," Ven Manda, Medtronic's RCS business president, and NewCo CEO upon close.